UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...